Citation: Nakagawa M., Yamamoto H., Kawaji M., Miura N., Wakame K., Endo T. Effects of lactic acid bacteria-containing foods on the quality of sleep: a placebo-controlled, doubleblinded, randomized crossover study. Functional Foods in Health and Disease 2018; 8(12): 579-596. https://doi.org/10.31989/ffhd.v8i12.572 ABSTRACT Background: There are various types of sleep disorders, such as insomnia, hypersomnia, and rhythm disorder, which are attributed to diverse and complex background factors. Recently, many studies have reported that lactic acid bacteria, bifidobacteria, and lactoferrin, are related to fatigue and sleep. Considering these factors, we prepared test food samples containing lactic acid bacteria ingredients (fermentation products, living bacteria, and ground bacteria) derived from the lactic acid bacterium strain Lactobacillus helveticus MIKI-020 (LBH MIKI-020) and theanine, which is known to have a relaxing effect. We then tested and observed the effects of lactic acid bacteria on the quality of sleep.
INTRODUCTION
There are various types of sleep disorders, such as insomnia, hypersomnia, and rhythm disorder, which are attributed to diverse and complex background factors. Insomnia is the most common type of sleep disorder. In Japan, 1 in 5 individuals are estimated to suffer from insomnia. 1 in 20 individuals use sleeping pills. These figures reportedly increase with increasing age. Previously reported causes of insomnia include aging, sleep apnea syndrome, atopic dermatitis, depression/anxiety disorder, inappropriate use of caffeine/alcohol, inappropriate use of electronic devices, climacteric disorder, increased urinary frequency, night shift, etc. [1] .
While complex exogenous and endogenous factors are involved in sleep disorder, there are many research reports on the circadian sleep rhythm. For example, blood levels of endocrine substances, such as melatonin and cortisol, undergo diurnal changes as they are deeply involved in arousal from sleep [2, 3] .
Recently, many studies have reported that lactic acid bacteria, bifidobacteria, and lactoferrin are related to fatigue and sleep. In a human clinical study, Ooki et al. reported that 8-week consumption of a bifidobacteria-containing food improved QOL, quality of sleep, and mood state [4] . These effects are attributable to the secretion of serotonin by Bifidobacterium, which acts as a neurotransmitter. In a human clinical trial, Uesaki et al reported that a lactoferrin-containing health food reduced stress, improved drowsiness on awakening, and had a positive effect on recovery from fatigue [5] . The improvement of intestinal flora by lactoferrin may be responsible for these effects, suggesting that the intestinal environment and brain function affect each other (gut-brain interaction).
Considering these factors, we prepared test food samples containing lactic acid bacteria ingredients (fermentation products, living bacteria, and ground bacteria) derived from the lactic acid bacterium strain Lactobacillus helveticus MIKI-020 (LBH MIKI-020) and theanine, which is known to have a relaxing effect [6] . We then tested its effects on the quality of sleep using subjective and objective measures.
STUDY DESIGN Eligibility criteria
Individuals who satisfied the inclusion criteria and did not meet the exclusion criteria were eligible to participate in this study. Inclusion criteria were men and women aged 20-64 years who have a problem with everyday sleep. Exclusion criteria were the following: (1) history of diabetes, hepatic disease, renal disease, gastrointestinal disease, peripheral vascular disease, or other serious diseases; (2) impaired cardiopulmonary function; (3) abnormal test results for liver function and kidney function; (4) had undergone surgery of the gastrointestinal tract; (5) had a disease under treatment during the study period; (6) allergic to food or drugs; (7) engagement in intense sports or diet; (8) consumption of a health food, quasi-drug, or drug (including OTC and prescription drugs) expected to improve bowel movement or insomnia; (9) consumption of excessive alcohol or unable to abstain from the consumption alcohol during a measurement period of sleep encephalograms or daytime activity meter (from the day before examination to the day of the examination); (10) pregnancy, expected pregnancy, or breast-feeding during the study period; (11) participation or planning to participate in any other clinical trials at the commencement of this study; (12) individuals whom investigators consider inappropriate for participation.
Targeted sample size 78 participants were recruited and underwent a preliminary survey. The study included 40 subjects (20 subjects in the test food group, and 20 subjects in the placebo control food group) who met all the selection criteria and none of the exclusion criteria.
Study outline
This study was conducted in compliance with the spirit of Declaration of Helsinki (adopted in 1964, Fortaleza amendment in 2013) and ethical guidelines on medical research on humans (2014 Ministry of Education, Culture, Sports, Science and Technology/Ministry of Health, Labor and Welfare Notification No. 3). This study was approved by the Ethical Review Board of Miura Clinic (approval number: R1604). Prior to participation, subjects received adequate oral and written explanations about this study, including its purpose and procedures, and provided written consent to participation.
This was a placebo-controlled, double-blinded, randomized crossover study. After obtaining written consent, the assigner randomly allocated 20 subjects each to the test food group and the placebo control group using random numbers. The subjects underwent medical interviews and laboratory tests on VISIT 1 and VISIT 2 (which was 4 weeks after VISIT 1). After a 6-week washout period, subjects underwent similar tests on VISIT 3 and VISIT 4 (which was 4 weeks after VISIT 3) (Fig1) ( Table 1) . Additionally, each subject was provided with a sleep electroencephalograph to measure sleep electroencephalogram (EEG) at home. The subjects were instructed to comply with restrictions (as described below) and prohibitions during the study period.
Restrictions
Investigators instructed the subjects to comply with the following restrictions during the study period:
1. Lifestyle such as diet, drinking, exercise, sleeping, and smoking should not be remarkably changed during the study period from those before study participation. 2. Avoid excessive exercise and abstemious diet or overeating that deviates from the range of daily life. 3. Consumption of pharmaceutical products (including those for external use), newly designated quasi-drugs, traditional Chinese medicines, health foods, and supplements are prohibited. If the use of any of these products is necessary for unavoidable reasons (such as poor physical condition) subjects should consult the contract research organization in advance. 4. The amount or frequency of consumption of foods/beverages expected to improve insomnia or regulate the function of intestine (e.g., yoghurt, lactic acid bacteria, Bifidobacterium, kimchi, natto, oligosaccharides, and indigestible dextrin) should not be changed during the study period from what it was before study participation. 5. Alcohol consumption and excessive exercise are prohibited from the day before the examination until the examination is completed. 6. No eating or drinking (except for water and lukewarm water) from after 10 PM of the day before the examination until the examination is completed. 7. Visit the hospital without eating the test food on the day of examination. The subjects ingested the tablets with or without chewing in the month within 30 minutes after dinner (or the first meal of the day if the subject did not eat dinner).
EXAMINATIONS

Physical examination and laboratory test items
Body height; body weight; systolic and diastolic blood pressure; pulse; blood levels of uric acid, urea nitrogen, AST (GOT), ALT (GPT), γ-GTP, ALP, LDH, total bilirubin, total protein, albumin, creatinine (Cre), CPK, serum amylase, total-Cho, HDL-Cho, LDL-Cho, triglycerides, glucose, Na, Cl, K, Mg, Ca, and Fe; hematologic parameters; qualitative urine tests for protein, glucose, urobilinogen, bilirubin, occult blood, and ketone body; and urine specific gravity and pH were measured.
Sleep electroencephalography
On VISIT 1 examinations, each subject received a sleep electroencephalograph (Brain wave sensor ZA, Proassist Ltd., Osaka) and an explanation of how to use it. Subjects measured sleep EEGs at home for 3 days after VISIT 1 examinations. Subjects also measured sleep EEGs for 3 days before VISIT 2 examinations. Subjects consumed the test food for 4 weeks from 3 days after VISIT 1 examinations. After a 6-week washout period after VISIT 2 examinations, subjects underwent VISIT 3 examinations. Similar to VISIT 1 examinations, VISIT 3 examinations Nonoue et al. (2017) . The recorded data were manually scored by one scorer, using the American Academy of Sleep Medicine Manual for Scoring Sleep 2007. Scorer was kept blinded to any background data for the subject of recorded data. The scoring software is SleepSign ver.3.3 (Kissei Comtec, Nagano, Japan). After sleep stage scoring was done, the sleep-related parameters were calculated as shown in Table 2 . 
Subjective evaluation
In total, subjects were administered four surveys on the following items in OSA sleep questionnaire, PSQI, and VAS questionnaire on VISITS 1, 2, 3, and 4. The OSA sleep survey (MA version) [7] was consists of sixteen adjectives with responses rated on a 0-4 scale which can be consolidated into five factors as the following: (1) sleepiness on rising; (2) initiation and maintenance of sleep; (3) frequent dreaming; (4) refreshing; (5) sleep length. The OSA-MA score was calculated using an MS-Excel sheet.
The PSQI (Japanese version version) sleep difficulty survey [8, 9] was conducted on the 7 items: (1) quality of sleep; (2) sleep-onset time; (3) sleep duration; (4) sleep efficiency; (5) sleep disturbance; (6) use of sleep medications; and (7) daytime dysfunction.
The VAS questionnaire survey was conducted on the following 12 items: (1) feeling of physical fatigue; (2) feeling of mental fatigue; (3) speed of thinking (confusion); (4) healing of tiredness; (5) ability to concentrate; (6) motivation (liveliness); (7) lightness of the body; (8) mood; (9) calmness; (10) awakening; (11) onset of sleep; and (12) subjective sleep duration.
Evaluation of adverse events
Adverse events included any undesirable or unintended injuries and diseases or signs thereof (including abnormal laboratory test results) that occurred in subjects regardless of whether there is a causal relationship with the study. The investigators made distinctions between subjective findings (i.e., subjective symptoms of the subjects) and objective findings (i.e., adverse events). Abnormal laboratory tests results were identified as adverse events by the investigators based on reference values of the study site.
Statistical analysis
All subjects who completed all the prescribed examinations and surveys as scheduled and did not meet any of the following exclusion criteria for the analysis set were included in efficacy analyses: (1) those who conspicuously engaged in behavior negatively impacting the reliability of test results, such as missing information in the diary; (2) those with less than 70% adherence to the test food regimen; and (3) those who did not satisfy the eligibility criteria for participation or were not capable of complying with the restrictions after enrollment.
Changes from data obtained before the consumption of the test food were compared between the test food group and the control food group using paired t-test for results of sleep encephalography and OSA sleep questionnaire survey, in addition to the Wilcoxon signed rank test for results of PSQI and VAS questionnaire surveys.
RESULTS
Inclusion and drop-out
Of 78 volunteers who participated in the preliminary examination, 38 were excluded for reasons such as low PSQI scores. Finally, 40 were included in this study. The selected subjects were 20 men and 20 women (mean age, 51.5 ± 9.0 years). Afterwards, one subject withdrew at week 0 examination. One subject dropped out for personal reasons after the start of the study. Out of the 38 subjects who completed the study, 19 were excluded from statistical analyses for reasons such as difficulties in measuring EEGs and failure of data recording. As a result, for 21 subjects who could measure sleep EEGs were included in analyses for all items (11 men and 10 women; mean age, 53.6 ± 6.9 years). (Fig 2)   Figure 2 . Flow diagram of the subjects who participated in this trial. Table 3 shows the results of sleep electroencephalography. The intergroup comparison in changes of the sleep efficiency (SE) until the 4th week showed a significant increase (improvement): control food group, −0.70 ± 5.69%; test food group, 2.13 ± 4.34% (p = 0.0342). Additionally, the SE was compared within the group. In the test food group, the SE increased (improved) significantly in 4 weeks: week 0, 93.29 ± 6.90%; week 4, 95.41 ± 4.16% (p = 0.0360). Each value is shown as the mean ± SD. Statistical differences were evaluated by paired t-test. † p < 0.05 among the groups, * p < 0.05 versus baseline (n=21). Table 4 shows the results of standardized scores of the OSA sleep survey. No significant differences were found between the groups. In intragroup analyses between week 0 and week 4, significant increases (improvements) were found in the test food group in terms of four out of the following five factors: factor I, sleepiness on awakening; factor II, onset and maintenance of sleep; factor III, dreaming; and factor IV, recovery from fatigue (p <0.05). In the control food group, a significant increase (improvement) was noted only for factor IV (p = 0.0156). Each value is shown as the mean ± SD. Statistical differences were evaluated by Wilcoxon signed-rank test. ** p < 0.01, * p < 0.05 versus baseline (n=21). Table 5 shows the results of PSQI scores. No significant differences were found between the groups. In intragroup comparisons between week 0 and week 4, significant decreases (improvements) were found in the test food group for the following factors: C1, quality of sleep (p = 0.0020) and total score (p = 0.0046). In the control food group, significant decreases (improvements) were noted for the following factors: C1 (p = 0.0313) and C7, daytime awakening difficulty (p = 0.0059). Table 6 Each value is shown as the mean ± SD. Statistical differences were evaluated by Wilcoxon signed-rank test. ** p < 0.01, * p < 0.05 versus baseline (n=21).
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Evaluation of adverse events
Changes in the physical examination results were within the range of physiological fluctuations of the subjects, and the investigators considered that there was no problem. Additionally, changes in laboratory test results over time were within the range of the subjects' characteristic values or physiological fluctuations and were considered no clinical problem. However, some subjects demonstrated changes beyond the range of reference values. Subjects reported some subjective symptoms, which emerged the day after ingestion of the test food and could not be attributed to any specific cause.
Although their causal relationships with the test foods could not be ruled out, all symptoms were mild and disappeared after the completion of ingestion. As a result, the investigators did not consider these incidents as adverse events (Tables 7-9). Each value is shown as the mean ± SD. Statistical differences were evaluated by Wilcoxon signed-rank test. † p < 0.05 among the groups, ** p < 0.01, * p < 0.05 versus baseline (n=21). [10] [11] [12] as well as positive effects on lipid metabolism [13, 14] , gut-brain interaction [15, 16] , and circadian rhythm [17] . Based on various functions of lactic acid bacteria, we studied their effects on the quality of sleep using subjective evaluations (i.e. questionnaires) and objective evaluations (i.e. electroencephalography) and revealed improvement of some of the indices of sleep and fatigue. Specifically, in addition to the quality of sleep, Feeling of physical fatigue, Motivation (liveliness), and Calmness improved after ingesting a test lactic acid bacteria-containing food. The SE also improved in the test food group, although no intergroup differences were seen in the sleep duration. The SE is a measure indicating a ratio of actual sleeping time to time in bed. Both the ratio and length of arousal during sleep tended to improve in the test food group. Therefore, the findings of the study suggest that the consumption of LBH MIKI-020 improved the quality of sleep, thereby improving the feeling of physical fatigue and motivation. The portable recording system (ZA) used for objective sleep evaluation is a highly reliable system to accurately understand the sleep state. The portable recording system (ZA) is made up of a wireless transmitter and a receiver. Electrodes attached to the forehead and the rims of eyes on both sides transmit digitally converted signals to the receiver placed on the bedside, which stores the sleeprelated EEG information [18] .
LBH MIKI-020, the lactic acid bacterium strain used in this study, was isolated from a newborn baby and is used in a drink product for health promotion and nutritional supplementation in children [19] . The lactic acid bacteria-containing food prepared as the test food contained a mixture of fermentation products, living bacteria, and ground bacteria of LBH MIKI-020. Many studies have shown that useful bacteria, such as lactic acid bacteria, generally produce some activity upon ingestion whether they are live or killed bacteria or simply their metabolites. Examples of such activities include intestinal regulation action based on the improvement of the intestinal environment and antiallergic action via immunomodulation [20, 21] . The test food contained theanine (200 mg/day) in addition to the LBH MIKI-020; theanine reportedly has a relaxation effect and improves the quality of sleep [6, 22] . However, previous studies have not addressed the improvement of subjectively assessed the quality of sleep by theanine. Under these circumstances, the test food was prepared to test if theanine and lactic acid bacteria work synergistically.
We consider that the lactic acid bacteria-containing food improved the quality of sleep in this study because of the following reasons. Recent studies have shown that body temperature changes represent an important factor in the circadian rhythm [23, 24] . Deep body temperature increased in the day and decreased in the night, while peripheral cutaneous temperature was elevated in the night. These diurnal changes in body temperature are reportedly necessary for balanced heat production and heat dissipation in the body and are deeply involved in the emergence of REM/non-REM sleep [25, 26] . As a possible link between this phenomenon and the mechanism of sleeping, peroxisome proliferator-activated receptor alpha (PPARα) agonists and other drugs that accelerate lipid metabolism have been reported to be involved in the regulation of the biological clock and improvement of the circadian rhythm in sleep disorders [27] . PPARα agonists induce fibroblast growth factor 21 (FGF21) expression in the liver, which reaches the brain and induces the expression of neuropeptide Y (NPY), thereby resulting in hypothermia [28] [29] [30] [31] . Furthermore, levels of serotonin in the brain were reduced by decreasing enteric bacteria in experiments in mice [32] . Killed lactic acid bacteria have been reported to improve not only the intestinal environment but also lipid metabolism via PPARα in a mouse model [33] , suggesting that they regulate body temperature through FGF21 production.
On the basis of these findings, to clarify its mechanism of action, we plan to study the effects of LBH_MIKI-020 alone on the PPARα ligand action, the deep body temperature lowering action via liver FGF21 production, and effects on the endocrines involved in the circadian rhythm in the future.
CONCLUSION
The results of the present study suggest that SE improved by continuous consumption of lactic acid bacteria-containing foods. Among various sleep disorders, a large population in Japan has trouble with the quality of sleep. Consumption of lactic acid bacteria-containing foods can be a useful means to safely improve the quality of sleep from the viewpoint of self-medication as well. Future tasks include further clarification of active ingredients and mechanism of action.
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